This content is machine translated Advanced melanoma Pembrolizumab is superior to ipilimumab There is news on the KEYNOTE-006 study evaluating pembrolizumab (Keytruda®) for the treatment of advanced melanoma. The study was terminated early after the defined endpoints consisting of progression-free and overall…
